These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9413091)

  • 1. Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
    Hulskotte EG; Dings ME; Norley SG; Osterhaus AD
    Vaccine; 1997 Dec; 15(17-18):1839-45. PubMed ID: 9413091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
    J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene.
    Ibuki K; Ido E; Funahashi S; Miura T; Hayami M; Shida H
    Vaccine; 1999 Oct; 18(5-6):511-6. PubMed ID: 10519941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories.
    Hulskotte EG; Rimmelzwaan GF; Boes J; Bosch ML; Heeney JL; Norley SG; de Vries P; Osterhaus AD
    Vaccine; 1995 Sep; 13(13):1187-97. PubMed ID: 8578803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
    Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
    Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.
    Ahmad S; Lohman B; Marthas M; Giavedoni L; el-Amad Z; Haigwood NL; Scandella CJ; Gardner MB; Luciw PA; Yilma T
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):195-204. PubMed ID: 8198872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
    Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.
    Hu SL; Stallard V; Abrams K; Barber GN; Kuller L; Langlois AJ; Morton WR; Benveniste RE
    J Med Primatol; 1993; 22(2-3):92-9. PubMed ID: 8411113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks.
    Habib M; Hussain I; Irshad H; Yang ZZ; Shuai JB; Chen N
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):660-4. PubMed ID: 16845721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response elicited by highly attenuated variants of vaccinia virus and by an attenuated recombinant expressing HIV-1 envelope protein.
    Dallo S; Maa JS; Rodriguez JR; Rodriguez D; Esteban M
    Virology; 1989 Nov; 173(1):323-9. PubMed ID: 2510402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
    Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.
    Fuller DH; Simpson L; Cole KS; Clements JE; Panicali DL; Montelaro RC; Murphey-Corb M; Haynes JR
    Immunol Cell Biol; 1997 Aug; 75(4):389-96. PubMed ID: 9315483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
    Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
    J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.